RecruitingPhase 2NCT05754801

Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer

Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer: A Randomized, Double-blinded, Placebo-controlled Trial


Sponsor

Chinese University of Hong Kong

Enrollment

172 participants

Start Date

Jan 5, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

A randomized, double-blinded, placebo-controlled clinical trial using a Chinese Medicine 'Coriolus Versicolor for improving the quality of life of patients with advanced-stage cancer. Subjects will be randomized into a treatment group or placebo group for 6 months.


Eligibility

Min Age: 21 YearsMax Age: 89 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo and a drug called Yunzhi Essence for people with cancer and palliative care. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years to 89 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGYunzhi Essence

Yunzhi Essence capsule

OTHERPlacebo

Placebo capsules


Locations(1)

School of Chinese Medicine

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05754801


Related Trials